Dr Abdul Mannan: The Mentzer Index Remains a Cornerstone Screening Tool in Haematology
Dr Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn:
“The Mentzer Index: A Valuable yet Imperfect Tool
The Mentzer Index remains a cornerstone screening tool in haematology.
It offers immediate differentiation between iron deficiency anaemia and β-thalassaemia trait using routine FBC parameters—no additional cost, no delay.
Its elegance lies in its simplicity: MCV divided by red cell count. However, limitations are critical: grey zone cases (MI 11–15), dual pathology, and α-thalassaemia confound interpretation.
The index guides, not diagnoses—confirmatory ferritin and HbA₂ quantification remain mandatory. In resource-limited settings, it prioritises costly testing.
In high-resource settings, it prevents diagnostic delay. Never use in isolation; always integrate clinical context, ethnicity, and family history.
The Mentzer Index exemplifies evidence-based medicine: a simple calculation with profound clinical impact when used judiciously.”
Title: Mentzer Index — Evidence-Based Review
Authors: Dr Abdul Mannan FRCPath FCPS
Read full article here.
Stay informed with Hemostasis Today.
-
Feb 2, 2026, 17:21Tagreed Alkaltham: Some Risks Don’t Look Like Risks in Healthcare
-
Feb 2, 2026, 17:16Sifat Jubaira: Effect of Prolonged Tourniquet Application
-
Feb 2, 2026, 17:14Vivek Mahto: Understanding Deep Vein Thrombosis – Causes, Symptoms, and Prevention
-
Feb 2, 2026, 17:08Tareq Abadl: Heparin vs Warfarin
-
Feb 2, 2026, 17:07Mary Cushman: New Research on Aspirin Use in Pregnancy and Stroke Risk in Offspring
-
Feb 2, 2026, 16:52Aravind Palraj: Young Stroke is Never Just Stroke
-
Feb 2, 2026, 16:48Seyed Mohsen Jahromi Moghadam: Antithrombotic Therapy After Transcatheter Structural Heart Interventions
-
Feb 2, 2026, 16:45Shashank Joshi: Switching Among Oral Anticoagulants
-
Feb 2, 2026, 16:40Zeinab Mubarak: How do Women Benefit from Menstrual Blood?